Skip to content
Clinical Trials – home
Therapeutic area

Psychiatric disorders – page 23

  • 546 clinical trials
  • 252 recruiting
  • 147 conditions
  • 26 countries

Conditions in this area

147 conditions with trials, the busiest first

Clinical trials in Psychiatric disorders

546 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

546 clinical trials

Anxiety

Not yet recruiting

Efficacy of Etifoxine in Adults with Adjustment Disorder with Anxiety: A Randomized, Double‑Blind, Placebo‑Controlled Trial

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Etifoxine Hydrochloride
  • Sponsor:Biocodex

Treatment of Post‑Traumatic Stress Disorder with inhaled nitrous oxide, oxygen, and nitrogen in adults: a multicenter randomized controlled trial

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Nitrogen
  • Sponsor:Centre Hospitalier Regional Universitaire De Tours

Dementia Alzheimer's type

Not yet recruiting

A Phase 2 Study of TML-6 in Adults with Early Alzheimer’s Disease to Evaluate Safety, Tolerability, and Efficacy

Investigational
Countries:SwedenSweden
  • Participants:65+ years

Anorexia nervosa

Not yet recruiting

Dry extract from Psilocybe cubensis (15‑25:1) with methanol for adults with treatment‑resistant anorexia nervosa: a randomized, active‑placebo, triple‑blind trial

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
  • Sponsor:Slagelse Hospital

Bipolar disorder

Not yet recruiting

Effect of Adjunctive Pramipexole on Anhedonia in Adults with Bipolar Depression – Randomized, Double‑Blind, Placebo‑Controlled Phase III Trial

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Pramipexole
  • Sponsor:Region Skane

Dementia Alzheimer's type

Not yet recruiting

Phase 2 Randomized Study of Mivelsiran in Adults with Early-Stage Down Syndrome-Associated Alzheimer’s Disease

Investigational
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:ALN-961583
  • Sponsor:Alnylam Pharmaceuticals Inc.

Brain injury

Not yet recruiting

Intranasal remestemcel therapy for newborns with hypoxic‑ischemic brain injury: a phase II placebo‑controlled trial

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years
  • Substances:Remestemcel
  • Sponsor:Universitair Medisch Centrum Utrecht

Depression

Not yet recruiting

Effect of dry extract from Psilocybe cubensis (15‑25:1), extraction solvent methanol, with psychotherapy versus basic support on depressive symptoms in adults with depression

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
  • Sponsor:Koebenhavns Universitet

Major depression

Not yet recruiting

A Phase 2 Study of Methylenedioxymethamphetamine‑Assisted Therapy in Young Adults (18‑25) with Chronic Treatment‑Resistant Major Depressive Disorder

InvestigationalNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Sponsor:Ostfold Hospital Trust

Psychotic disorder+2

Not yet recruiting

A Randomized Controlled Trial of Cannabidiol vs Placebo Augmentation in Patients with First Episode Psychosis

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years
  • Substances:Cannabidiol
  • Sponsor:University Of Oxford

Major depression

Not yet recruiting

Effect of Stopping Ethinylestradiol/Levonorgestrel Contraceptive on Mood and Memory in Adults with Major Depressive Disorder on Antidepressant Combination

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Duloxetine
  • Sponsor:Region Hovedstaden

Obesity+1

Not yet recruiting

Tirzepatide versus CPAP and Lifestyle Modification for Obstructive Sleep Apnea in Adults ≥ 65 years with Overweight or Obesity – Randomized Trial

Registered drugNo placebo
Countries:SpainSpain
  • Participants:65+ years
  • Substances:Tirzepatide
  • Sponsor:Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre

Substances studied in this area

The therapies tested most often in Psychiatric disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.